The target action date for orforglipron is now April 10.

In December 2025, the U.S. Food and Drug Administration gave the green light to a pill version of the blockbuster weight loss drug Wegovy, the first FDA-approved daily oral GLP-1 medication for ...

Learn how new oral GLP-1 weight loss pills work, how they compare with injections, and how the next generation of “small ...

(The Hill) – The Food and Drug Administration (FDA) has approved Novo Nordisk’s oral version of the Wegovy weight-loss pill, the first such supplement approved for use. Novo Nordisk said in a Tuesday ...

The US Food and Drug Administration (FDA) has approved a once-daily oral GLP‑1 medicine to help people reduce excess body weight and maintain weight loss over the long term. The Novo Nordisk treatment ...

How to Get Prescribed Ozempic for Weight Loss This article was reviewed by Lynn Marie Morski, MD, JD Ozempic is FDA-approved for type 2 diabetes but sometimes prescribed ...

Eli Lilly (NYSE:LLY) shares edged 0.9% lower in premarket trading on Thursday after the U.S. Food and Drug Administration postponed its decision on the company’s weight-loss pill until April 10. The ...

The Food and Drug Administration is approving a weight loss drug from Vivus Inc. that many doctors consider the most effective among a new generation of anti-obesity pills. The agency cleared the pill ...

A new study found that a combination of hormone therapy and the GLP-1 medication tirzepatide (Zepbound) led to 35% more ...

JONESBORO, Ark. (KAIT) - The U.S. Food and Drug Administration approved the pill version of Wegovy on Dec. 22, marking the first FDA-approved GLP-1 pill for chronic weight management. Dr. Shane ...

An oral formulation of semaglutide has received United States Food and Drug Administration approval for a new drug or biologic under the Prescription Drug User Fee Act. Researchers found that oral ...

As a youth activist in Colorado, I’ve spent years organizing around the issues that shape our generation’s lives — and across ...